Viewing StudyNCT06361316



Ignite Creation Date: 2024-05-06 @ 8:24 PM
Last Modification Date: 2024-10-26 @ 3:26 PM
Study NCT ID: NCT06361316
Status: RECRUITING
Last Update Posted: 2024-04-11
First Post: 2024-03-25

Brief Title: Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
Sponsor: Kuirong Jiang
Organization: The First Affiliated Hospital with Nanjing Medical University

Organization Data

Organization: The First Affiliated Hospital with Nanjing Medical University
Class: OTHER
Study ID: CSPC-DEY-PC-JS01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Kuirong Jiang
Lead Sponsor Class: OTHER
Responsible Party: Kuirong Jiang
Responsible Party Title: archiater
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation: The First Affiliated Hospital with Nanjing Medical University
Old Name: None
Old Organization: None

Collaborators

Name Class
CSPC Ouyi Pharmaceutical Co Ltd INDUSTRY